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Peft Atrial Volume Predicts the Risk
f Atrial Fibrillation After Cardiac Surgery
Prospective Study
artin Osranek, MD, MSC,* Kaniz Fatema, MD, PHD,* Fatema Qaddoura, MD,*
hmed Al-Saileek, MD,* Marion E. Barnes, MSC,* Kent R. Bailey, PHD,†
ernard J. Gersh, MB, CHB, DPHIL, FACC,* Teresa S. M. Tsang, MD, FACC,*
enton J. Zehr, MD,‡ James B. Seward, MD, FACC*
ochester, Minnesota
OBJECTIVES This study sought to identify preoperative predictors of postoperative atrial fibrillation
(POAF) among patients undergoing cardiac surgery.
BACKGROUND Postoperative atrial fibrillation is frequent after cardiac surgery and is associated with
increased morbidity, mortality, prolonged hospital stay, and increased costs. Left atrial
volume (LAV), a marker of chronically elevated left ventricular filling pressure, is a predictor
of atrial fibrillation (AF) in the nonsurgical setting.
METHODS A total of 205 patients (mean age 62  16 years; 35% women) undergoing cardiac surgery
were prospectively enrolled. Clinical risk factors were obtained by detailed medical record
review and patient interview. Preoperative transthoracic echocardiograms were performed for
assessment of LAV, left ventricular ejection fraction, and diastolic function. Follow-up was
complete. Detection of POAF was based on documentation of AF episodes by continuous
telemetry throughout hospitalization.
RESULTS Postoperative atrial fibrillation occurred in 84 patients (41.4%) at a median of 1.8 days after cardiac
surgery. The LAV was significantly larger in patients in whom AF developed (49 14 ml/m2 vs.
39  16 ml/m2, p  0.0001). Patients with LAV 32 ml/m2 had an almost five-fold increased
risk of POAF, independently of age and clinical risk factors (adjusted hazard ratio 4.84, 95%
confidence interval 1.93 to 12.17, p 0.001). Age and LAV were the only independent predictors
of POAF. The area under the receiver-operator characteristics curve to predict POAF was 0.729
for LAV and 0.768 for the combination of LAV and age (both p  0.0001).
CONCLUSIONS The LAV is a strong and independent predictor of POAF. Risk stratification using LAV and
age enables clinicians to identify high-risk patients before cardiac surgery. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.03.054Cardiol 2006;48:779–86) © 2006 by the American College of Cardiology Foundation
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Postoperative atrial fibrillation (POAF) is common after
ardiac surgery and is associated with increased morbidity,
ortality, and prolonged hospital stay (1–4). The impact of
OAF on hospital resources is substantial, with annual
stimated expenditures exceeding $1 billion in the U.S. (3).
he risk for perioperative stroke is almost three-fold higher
or patients with POAF (1,3). Recently, a retrospective
See page 787
tudy of patients undergoing mitral valve surgery showed
hat POAF was independently associated with stroke,
ongestive heart failure, and AF at 10-year follow-up (5).
he incidence of POAF varies depending on definition,
atient characteristics, type of operation, and method of
rrhythmia monitoring (1–4). In a large series, Creswell
t al. (1) found the incidence of POAF detected by contin-
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merican Heart Association (0525771Z) and the Austrian Science Fund
Schrödinger Stipend, J2289-B02).t
Manuscript received December 12, 2005; revised manuscript received March 17,
006, accepted March 21, 2006.ous electrocardiographic telemetry monitoring to be 32%
fter coronary artery bypass grafting (CABG), 42% after
itral valve surgery, 49% after aortic valve surgery, and 62%
fter combined CABG and valve surgery.
Several risk indices provided adequate discriminative
ower to identify patients with POAF. However, they
ncluded mainly intraoperative and postoperative variables
2,6), and are therefore not clinically helpful for risk
tratifying patients before surgery who may benefit from
reoperative preventive antiarrhythmic therapy.
Left atrial volume (LAV) can be measured easily before
urgery, and increased LAV has been shown to predict the
evelopment of AF in nonsurgical populations (7), but its utility in
he prediction of POAF is unknown. The increase in LAV is
emodynamically closely related to the chronic burden of elevated
entricular filling pressure (8,9) and diastolic dysfunction (10).
In the current study, we hypothesized that LAV, as a
urrogate measure of preoperative chronically increased
lling pressure, is an independent predictor of POAF and
epresents a clinically useful test for risk stratification.
ATERIALS AND METHODS
atient selection. After approval of the study protocol by
he institutional review board, consecutive patients sched-
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Left Atrial Volume and Postoperative AF August 15, 2006:779–86led to undergo open heart surgery at the Mayo Clinic,
ochester, Minnesota, were prospectively enrolled on the
ay before surgery. Participants had to be in sinus rhythm as
ocumented by 12-lead electrocardiogram. Patients under-
oing CABG surgery and surgery involving the aortic valve,
scending aorta, tricuspid valve, pericardium, cardiac
asses, and myectomy were eligible. We excluded patients
ith AF, past or planned Cox’s maze procedure, more than
oderate mitral valve stenosis or regurgitation, mitral valve
rosthesis, congenital cardiac abnormalities, emergency sur-
ery, or inability to provide informed consent. By excluding
itral valve disease or prosthesis, hemodynamic changes
urely related to mitral valve pathology that could poten-
ially affect LAV or impede diastolic function assessment
ere avoided.
linical variables. Demographic and baseline clinical data
ere obtained through Mayo Clinic Registration, review of
edical records, and a structured interview at enrollment.
aseline clinical variables included New York Heart Asso-
iation functional class, Canadian Cardiovascular Society
ngina class, history of AF, myocardial infarction, stroke,
istory of systemic hypertension (140/90 mm Hg, or
reated), diabetes mellitus, dyslipidemia (hypercholesterol-
mia, hypertriglyceridemia, reduced high-density lipopro-
ein cholesterol, or any combination), congestive heart
ailure requiring hospitalization, thyroid disorder, chronic
bstructive pulmonary disease, renal insufficiency, and
moking (current or past). Use of medications was docu-
ented. In particular, the preoperative use of beta-blockers,
ngiotensin-converting enzyme inhibitors, and angiotensin
eceptor blockers, as well as their postoperative withdrawal
r resumption, was assessed. Any antiarrhythmic medica-
ion that was given to prevent POAF was also noted.
linically indicated preoperative angiograms were evalu-
ted. The degree of stenosis in the individual coronary
rteries was noted. The number of vessels with significant
75%) stenosis was counted.
chocardiography. All preoperative echocardiograms were
eviewed in a blinded fashion. Offline measurements of
tudy variables were performed according to established
ethods (11–13). The LAV was obtained by the biplanar
rea-length method and indexed to body surface area as
reviously described (12,13). This validated method has
een shown to correlate better than LA diameter or mono-
lanar methods with the actual volume of the atrial chamber
Abbreviations and Acronyms
CABG  coronary artery bypass graft
CI  confidence interval
DFG  diastolic function grade
EF  ejection fraction
HR  hazard ratio
LAV  left atrial volume
POAF  postoperative atrial fibrillationecause it relies on fewer geometric assumptions (14–16). iFor the biplanar area-length method, the maximal LA
rea is planimetered at end-ventricular systole just before
pening of the mitral valve in the four- and two-chamber
iews. The recesses of the pulmonary veins and the LA
ppendage are excluded. The length of LA is that of the
erpendicular line measured from the middle of the plane of
he mitral annulus to the superior aspect of the LA. The
AV is calculated as: 0.85  four-chamber area  two-
hamber area  shorter of the two lengths. An LAV above
2 ml/m2 representing the upper 95th percentile of normal
ubjects (17) was used as a cutoff to define LA enlargement,
cutoff previously validated by our group for risk prediction
7,18,19). A random sample of 20 (10%) studies was
e-assessed by a co-investigator for quality assurance pur-
oses. The linear correlation (r  0.87, p  0.0001) was
ood, and the mean difference of 1.03 ml/m2 was not
ifferent from zero (p  0.47). From the same views, left
entricular ejection fraction (EF) was calculated using the
iplanar Simpson method.
Doppler interrogation of cardiac hemodynamics included
itral inflow peak early (E) and late (atrial, A) velocities,
eceleration time, pulmonary venous systolic and diastolic
orward flow velocities, and pulmonary vein atrial reversal
elocity. Tissue Doppler imaging of septal annulus motion
elocity (E=) was obtained. Resting left ventricular filling
ressures were estimated by the ratio of mitral E velocity
nd septal mitral annulus motion velocity (E/E=) (20).
Five diastolic function grades (DFG) were determined
11,21,22):
Normal: mitral E/A ratio of 0.75 to 1.5, mitral deceler-
ation time 150 to 240 ms, E/E= 8, pulmonary venous
systolic forward flow velocity  diastolic, pulmonary
venous atrial reversal 0.30 m/s.
Grade I: relaxation abnormality; mitral E/A ratio of
0.75, mitral deceleration time 240 ms, pulmonary
venous systolic forward flow velocity  diastolic.
Grade Ia: patients with a mitral inflow pattern consistent
with grade I but E/E= 10.
Grade II: pseudonormal filling; mitral E/A 0.75 to 1.5
(with decrease of 0.5 on Valsalva maneuver), mitral
deceleration time 150 to 240 ms, E/E= 10, pulmonary
venous systolic forward flow velocity  diastolic.
Grade III: restrictive filling; mitral E/A 1.5, mitral
deceleration time 150 ms, E/E= 15, pulmonary ve-
nous systolic forward flow velocity  diastolic.
atients with limited Doppler signal quality or discrepancy
mong Doppler measurements were not assigned a DFG to
void any misclassification.
Left ventricular mass was calculated and indexed to body
urface area. Pulmonary artery pressure was estimated with
he simplified Bernoulli equation [(4  tricuspid regurgita-
ion velocity)  estimated right atrial pressure]. Mitral
egurgitation was qualitatively described.
utcome ascertainment. Continuous telemetry record-ngs from surgery until hospital discharge were complete in
a
t
d
p
c
s
r
w
t
S
f
v
q
g
S
U
o
K
h
t
e
i
g
p
b
e
j
r
v
c
b
v
s
a
I
R
A
s
6
d
h
o
s
s
p
C
p
a
i
O
s
a
d
S
s
p
T
A
M
B
H
S
P
N
H
H
H
H
D
D
S
T
C
C
N
L
R
B
D
T
A
S
A
c
781JACC Vol. 48, No. 4, 2006 Osranek et al.
August 15, 2006:779–86 Left Atrial Volume and Postoperative AFll patients and were reviewed for POAF. Episodes of more
han 30 s were considered clinically relevant AF. A pre-
ismissal 12-lead electrocardiogram was performed on each
atient. Ventilation time, intensive care unit time and
linical postoperative complications, reoperation, bleeding,
hock, stroke, infection, death, arrhythmias other than AF,
enal failure, pulmonary complications, and length of stay
ere determined based on hospital notes and by contacting
he treating physician.
tatistical analysis. Data are presented as proportions (%)
or categorical variables and as mean  SD for continuous
ariables. For skewed variables, the median (first to third
uartile) is reported. Characteristics were compared across
roups using chi-square tests for categorical variables and
tudent t test for continuous variables. The Mann-Whitney
test was used for variables with skewed distributions.
To account for varying lengths of hospital stay, the main
utcome (POAF) was modeled using survival analyses: the
aplan-Meier product limit method and Cox proportional
azards models. Variables with a skewed distribution were
ransformed using natural logarithm. In Cox models, for
ach variable, the hazard ratio (HR), 95% confidence
nterval (CI), and p value are provided. Differences between
roups were tested using the log rank statistic, and inde-
endent predictors were identified in multivariable analyses.
Predictors identified in univariable analyses were used to
uild separate multivariable models for clinical, surgical, and
chocardiographic variables. All of these models were ad-
usted for age, which has been consistently found to be
elated to POAF. From these models, the significant
able 1. Baseline Characteristics
No AF (n  119)
ge (yrs) 56.9  17.6
en 77 (64.7%)
ody surface area (m2) 1.98  0.25
eart rate (min1) 66.3  11.3
BP (mm Hg) 128.5  17.4
P (mm Hg) 53.8  15.5
YHA functional class 1.06  1.21
istory of CHF 46 (38.6%)
istory of AF 11 (9.2%)
istory of MI 15 (12.6%)
ypertension 65 (54.6%)
iabetes mellitus 9 (7.6%)
yslipidemia 60 (50.4%)
moking 45 (37.8%)
hyroid disorder 12 (10.1%)
OPD 3 (2.5%)
hronic renal insuffiency 4 (3.4%)
o. of diseased vessels (n  157) 0.9  1.2
M stenosis (%) (n  157) 10.5  18.7
CA stenosis (%) (n  157) 35.4  39.4
eta-blocker 72 (60.5%)
iuretic 29 (24.4%)
hyroxin 12 (10.1%)
ntiarrhythmic therapy 6 (5.0%)
tatin 42 (25.3%)F  atrial fibrillation; CHF  congestive heart failure; CI  confidence interval; COP
oronary artery; NYHA  New York Heart Association; PP  pulse pressure; RCA  riariables that can be obtained before surgery in all patients,
omplemented by variables of clinical interest, were used to
uild a final model with at least 10 outcome events per
ariable to ensure model stability. A p value of 0.05 was
elected for the threshold of statistical significance. All
nalyses were performed using SPSS version 11.5 (SPSS
nc., Chicago, Illinois).
ESULTS
total of 205 consecutive patients undergoing cardiac
urgery were prospectively enrolled. The mean age was
2.0  16.3 years, and 34.6% were women. Two patients
ied intraoperatively, and two patients died during their
ospital stay. Patients in whom POAF developed were
lder, had higher systolic blood pressures and pulse pres-
ures, had a greater degree of left main coronary artery
tenosis, and were more likely to have chronic obstructive
ulmonary disease (Table 1). Combined aortic valve and
ABG surgery and the number of bypass grafts were
redictive of POAF. Intraoperatively, increased pulmonary
rtery pressure was associated with POAF, whereas other
ntraoperative variables and treatment were not (Table 2).
ccurrence of POAF. Of 203 patients surviving the
urgery (99.0%), 84 patients (41.4%) experienced POAF
fter a median (first to third quartile) of 1.8 days (1.2 to 2.9
ays) at a mean heart rate of 116  26 min1 and a mean
BP of 118  18 mm Hg. Thirty-three patients had a
ingle episode, 14 had multiple episodes, and 37 had
ersistent AF lasting longer than 24 h. The median total
(n  84) HR (95% CI) p Value
69  11.2 1.04 (1.02–1.05) 0.0001
6 (66.7%) 0.94 (0.60–1.48) 0.78
.99  0.23 1.17 (0.49–2.82) 0.72
7.3  11.6 1.01 (0.99–1.03) 0.54
5.1  19.2 1.01 (1.00–1.03) 0.02
0.2  17.4 1.02 (1.00–1.03) 0.01
.25  1.33 1.08 (0.91–1.28) 0.38
2 (50.0%) 1.25 (0.88–1.78) 0.25
2 (14.1%) 1.39 (0.75–2.56) 0.30
2 (14.3%) 1.14 (0.62–2.11) 0.67
3 (51.2%) 0.84 (0.55–1.29) 0.42
2 (14.3%) 1.51 (0.82–2.79) 0.19
0 (59.5%) 1.31 (0.85–2.02) 0.23
3 (51.2%) 1.47 (0.96–2.26) 0.08
1 (13.1%) 1.30 (0.69–2.45) 0.42
6 (7.1%) 2.40 (1.04–5.51) 0.04
6 (7.2%) 1.99 (0.86–4.60) 0.11
1.2  1.2 1.19 (0.98–1.43) 0.08
9.6  21.3 1.01 (1.00–1.03) 0.006
5.6  39.9 1.01 (1.00–1.01) 0.12
3 (63.1%) 1.05 (0.67–1.64) 0.82
9 (34.5%) 1.44 (0.92–2.26) 0.11
1 (13.1%) 1.26 (0.67–2.37) 0.48
4 (4.8%) 0.91 (0.33–2.48) 0.85
0 (47.6%) 1.40 (0.91–2.14) 0.13AF
5
1
6
13
6
1
4
1
1
4
1
5
4
1
1
4
5
2
1
4D  chronic obstructive pulmonary disease; HR  hazard ratio; LM  left main
ght coronary artery; SBP  systolic blood pressure.
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Left Atrial Volume and Postoperative AF August 15, 2006:779–86uration of POAF was 12 h, and the median single longest
pisode was 9 h. Seventy-one patients with POAF (84.5%)
id not experience symptoms at the onset of AF. Among
he 84 patients who experienced POAF, 13 (15.5%) did not
eceive any specific treatment, 2 (2.4%) underwent electrical
ardioversion, 67 (79.8%) were given drug treatment, and 2
2.4%) received both. Drugs used were class III antiarrhyth-
ics in 57 patients, beta-blockers in 12 patients, and
igitalis in 12 patients. Overall, more than one treatment
odality, including multiple antiarrhythmic drugs, was
eeded in 13 patients. Seven (8.3%) patients were dis-
harged from the hospital with AF.
Postoperative complications other than AF occurred in
2 patients (20.7%) and were not significantly associated
ith the incidence of POAF apart from a trend for renal
ailure (Table 3). All but 1 patient stayed at least 4 days in
he hospital and, according to telemetry recordings of the
omplete hospital stay, 76 (90.0%) of the 84 patients with
OAF experienced the event before the end of the fourth
ostoperative day. The median length of hospital stay was
ignificantly longer in patients with POAF compared with
hose without POAF (7 vs. 5 days, p  0.00001).
chocardiographic predictors of POAF. Among all
chocardiographic parameters, only DFG and LAV were
redictive of POAF. The DFG was successfully determined
n 181 (88.3%) patients and was moderately correlated with
AV (Fig. 1). Ventricular relaxation estimated by E= in 162
atients was close to being statistically significant. The
able 2. Univariable Surgical Predictors of POAF
No AF (n  119)
V  CABG 8 (6.7%)
umber of grafts 0.9  1.6
ntraoperative PA SBP (n  197) 26.5  8.1
ross-clamp time (min) 50.9  54.8
ardiopulmonary bypass time (min) 69.4  37.0
ntraoperative blood loss (l) 0.63  0.55
ntraoperative fluid balance (l) 4.40  2.42
henylephrine 79 (66.4%)
phedrine 59 (49.%)
smolol 23 (19.3%)
entilation [Log(h)] 2.2  0.8
CU time [Log(h)] 3.8  0.9
V  CABG  aortic valve and coronary artery bypass graft surgery; ICU  inte
bbreviations as in Table 1.
able 3. Postoperative Complications
No AF
(n  119)
AF
(n  84) p Value
ny complication 22 (18.5%) 20 (23.8%) 0.36
eoperation 8 (6.7%) 3 (3.6%) 0.33
yocardial infarction 1 (0.8%) 0 (0.0%) 0.40
ulmonary complications 6 (5.0%) 6 (7.1%) 0.53
nfection 4 (3.4%) 6 (7.1%) 0.22
enal failure 3 (2.5%) 7 (8.3%) 0.06
hock 1 (0.8%) 1 (1.2%) 0.80
troke 2 (1.7%) 0 (0.0%) 0.23
ther arrhythmia 6 (5.0%) 6 (7.1%) 0.53F  atrial fibrillation.
f
wFG had the strongest predictive value when considered as
ormal versus abnormal with a HR of 3.36 (95% CI 1.35
o 8.35).
At univariable analysis, LAV was the most powerful
redictor of POAF with a 26% increase in the risk of AF for
very 10 ml/m2 increase in LAV (HR  1.26, 95% CI 1.13
o 1.40, p  0.0001) and an HR of 6.55 (95% CI 2.65 to
6.18, p 0.0001) for patients with an abnormal LAV32
l/m2 (Table 4). The proportion of patients who experi-
nced any type of POAF increased with each quartile of
AV, as did the subgroup of persistent AF (Fig. 2A).
urvival free from POAF progressively worsened with
ncreasing quartiles of LAV (p  0.00001) (Fig. 2B). In a
ultivariable analysis of echocardiographic variables, only
AV remained a significant predictor of POAF (p 
.0001). The LAV tended to be larger in patients requiring
ultiple treatment modalities to convert to sinus rhythm
54.7  18.5 ml/m2 vs. 47.6  12.8 ml/m2, p  0.09) and
n those with symptoms at the onset of POAF (55.1 18.5
l/m2 vs. 47.5  12.8 ml/m2, p  0.07). An LAV 32
l/m2 was a significant predictor of POAF in patients with
p  0.007) and without beta-blockers (p  0.004).
F (n  84) HR (95% CI) p Value
24 (28.6%) 2.89 (1.79–4.64) 0.0001
1.7  1.8 1.20 (1.07–1.35) 0.002
30.1  10.9 1.03 (1.01–1.05) 0.002
51.7  26.3 1.00 (0.99–1.01) 0.96
74.0  35.1 1.00 (0.99–1.01) 0.61
0.66  0.56 0.97 (0.67–1.41) 0.88
4.92  2.74 1.04 (0.96–1.13) 0.29
51 (60.7%) 0.79 (0.51–1.23) 0.29
52 (61.9%) 1.49 (0.96–2.31) 0.08
10 (11.9%) 0.67 (0.35–1.30) 0.23
2.3  0.9 0.96 (0.75–1.23) 0.73
3.9  1.0 1.04 (0.83–1.31) 0.73
care unit; PA  pulmonary artery; POAF  postoperative atrial fibrillation; other
igure 1. Box plots of left atrial volume (LAV) according to diastolicAunction grade (DFG). Using linear regression, the correlation coefficient r
as 0.56 (p  0.0001).
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August 15, 2006:779–86 Left Atrial Volume and Postoperative AFinal model for the prediction of POAF. Apart from age,
AV indexed to body surface area was the only independent
redictor of POAF, with a 32% increase in the risk of AF
or every 10 ml/m2 increase in LAV (adjusted HR  1.32,
5% CI 1.15 to 1.52, p  0.0001) (Table 5). Compared
ith patients with a normal LAV, those with an abnormal
AV (32 ml/m2) had an almost five-fold increased risk of
OAF, independent of other risk factors (adjusted HR 
.84, 95% CI 1.93 to 12.17, p  0.001). When considering
nly persistent POAF, results were similar, with only LAV
adjusted HR  1.03, 95% CI 1.01 to 1.05, p  0.004) and
ge (adjusted HR  1.05, 95% CI 1.01 to 1.08, p  0.005)
merging as significant predictors.
Survival free of POAF, stratified by established cutoffs for
ge and LAV, was significantly different among the four
roups (p  0.00001) and is shown in Figure 3. No patient
nder the age of 65 years with a normal LAV experienced
OAF, and only 5 patients older than 65 years with a
ormal LAV had POAF. Conversely, the majority of events
n  64) occurred in older patients with enlarged atria.
To assess the predictive accuracy of this risk stratification,
e ranked the 4 possible combinations of normal/abnormal
AV and young/old according to the risk for AF that we
bserved in the Kaplan-Meier analysis shown in Figure 3,
nd assigned numeric values ranging from 0 to 3. In a
able 4. Univariable Echocardiographic Predictors of POAF
No AF (n  119)
AV 32 ml/m2 74 (62.2%)
AV (ml/m2) 39.2  16.3
bnormal DFG (n  179) 80 (74.8%)
FG (5 grades) (n  179) 1.7  1.4
= (cm·s1) (n  163) 7.1  3.1
/E= (n  162) 13.7  6.7
VARV (cm·s1) (n  145) 0.30  0.1
jection fraction (%) 59.9  12.4
itral regurgitation (trivial) 54 (45.4%)
V mass indexed (g/m2) (n  148) 125.3  40.5
A pressure (mm Hg) (n  157) 34.6  10.7
FG  diastolic function grade; E  peak early mitral inflow velocity; E=  early
rtery; PVARV  pulmonary vein atrial reversal velocity; other abbreviations as in Tigure 2. (A) Incidence of different types of postoperative atrial fibrillation (AF
o quartiles of left atrial volume (LAV). (B) Survival free from postoperative Aeceiver-operator characteristics analysis, the area under the
urve for this algorithm was 0.768, compared with 0.729
hen LAV was used as a continuous variable (both p 
.0001).
An LAV 32 ml/m2 and age 65 years identified
atients with POAF with 76.2% sensitivity and 71.4%
pecificity, for a positive predictive value of 65.5%. The
egative predictive value of LAV 32 ml/m2 or age 65
ears was 81.0%.
ISCUSSION
e found that LAV32 ml/m2 was the strongest predictor
f POAF, with an almost five-fold increased risk of POAF
ndependent of age and other clinical and surgical parame-
ers. There was a progressive increase in risk of POAF with
ncreasing quartiles of LAV, suggesting causality in terms of
dose response. The preoperative grade of diastolic func-
ion, although univariately associated with POAF and
AV, was superseded by LAV in multivariable analyses.
Other investigators have suggested various risk scoring
ystems for the prediction of POAF (2,6). Although some
chieved moderate degrees of accuracy, they are limited by
cumbersome point scoring system incorporating up to
ight variables (2). Importantly, apart from age, the vari-
F (n  84) HR (95% CI) p Value
79 (94.0%) 6.55 (2.65–16.18) 0.0001
48.7  13.9 1.02 (1.01–1.03) 0.0001
67 (93.1%) 3.36 (1.35–8.35) 0.009
2.3  1.1 1.26 (1.05–1.51) 0.015
6.1  2.5 0.92 (0.83–1.01) 0.07
15.0  6.6 1.01 (0.98–1.05) 0.38
0.32  0.2 3.11 (0.68–14.21) 0.14
57.9  12.1 0.99 (0.98–1.01) 0.40
49 (58.3%) 1.44 (0.93–2.23) 0.09
22.5  39.4 0.99 (0.99–1.00) 0.53
36.8  10.2 1.01 (0.99–1.03) 0.25
rdial relaxation; LAV  left atrial volume; LV  left ventricular; PA  pulmonary
1 and 2.A
1) (single episode, multiple episodes, persistent more than 24 h) according
F stratified by quartiles of LAV.
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ainly intraoperative or postoperative, such as postoperative
mpaired atrial function (23), postoperative low cardiac
utput (6), postoperative beta-blocker or angiotensin-
onverting enzyme inhibitor administration (2), or the
ostoperative use of adrenergic drugs (24). Furthermore, the
eneralizability of many studies is limited to specific types of
urgery (5,23) or by the exclusion of patients with a history
f atrial fibrillation (5,6,23,25), previous cardiac surgery
5,6), or antiarrhythmic therapy (25). Although the obser-
ations made in these studies are of interest and give insight
nto POAF, they are of limited clinical use and are unlikely
o be widely applied in practice. Conversely, we sought to
dentify a reproducible marker of the risk for POAF that can
e obtained before surgery and is consistent with a patho-
hysiological model derived from experimental research and
alidated in epidemiologic studies of nonsurgical AF.
ardiac filling pressures and AF. The pathophysiological
auses of elevated filling pressure have been attributed to
ndothelial dysfunction, vascular stiffening, up-regulation of
he renin-angiotensin-aldosterone system (26–28), delayed
yocyte relaxation, cell death, and fibrosis (29). The
hinned areas of atrial myocardium are vulnerable to stretch
aused by increased filling pressures (30). Myocyte stretch
ncreases the atrial effective refractory period dispersion
hrough mechano-electrical feedback and, amplified by
ollagen deposition, lowers the arrhythmogenic threshold
31,32). These observations have been confirmed in
ommunity-based cohorts using diastolic dysfunction as a
urrogate for elevated filling pressures to predict non–
urgery-related AF (33).
In the present study, resting DFG was defined according
o established criteria (11), and proved to be a strong
nivariate predictor of POAF. Early diastolic myocardial
elaxation velocity, which has been shown to correlate with
eft ventricular filling pressure (20), did show a trend toward
ignificance. Other investigators found that plasma B-type
atriuretic peptide levels, another marker of elevated ven-
ricular filling pressure (34), moderately predicted POAF
25). However, all of these measures are merely reflections
f a momentary state that is heavily dependent on loading
onditions. The latter are especially variable during the
able 5. Multivariable Cox Model Predicting POAF
HR (95% CI) p Value
ge (yrs) 1.04 (1.02–1.06) 0.0002
AV (ml/m2) 1.03 (1.01–1.04) 0.0001
istory of CHF 1.21 (0.77–1.92) 0.41
istory of AF 1.38 (0.73–2.61) 0.32
moking 1.50 (0.95–2.36) 0.08
ABG  AV 1.54 (0.88–2.70) 0.14
BP (mm Hg) 1.01 (0.99–1.02) 0.42
jection fraction (%) 1.00 (0.99–1.02) 0.65
 203; chi-square  49.94.
AV  CABG  aortic valve and coronary artery bypass graft surgery; CHF 
ongestive heart failure; LAV  left atrial volume; SBP  systolic blood pressure;
ther abbreviations as in Table 2.ourse of major surgery. Thus, the preoperative assessment
F
af diastolic function or B-type natriuretic peptide levels may
ive an indication of the average pathophysiological state of
group of patients before surgery, but is not a permanent
eature of individual patients that determines risk through-
ut varying conditions.
AV as a predictor of POAF. Our group and others have
hown that the measurable increase in LAV precedes the
nset of non–surgery-related AF (7,33). Enlarged atria are
est correlated with increased wall tension because of
ntermittent yet chronic elevation of ventricular filling pres-
ures (8–10). The relationship between LAV and diastolic
ysfunction has been compared with the association be-
ween glycosylated hemoglobin and serum glucose, i.e., as a
arker of the duration and severity of disease (10,33).
hronic myocyte stretch increases the intercellular matrix,
ollagen production, and fibrosis, mediated through the
enin-angiotensin-aldosterone system (35). Enlarged atria
eflect the remodeling process, and represent a quantifiable
urrogate of the arrhythmogenic substrate. The volume of
emodeled atria is relatively insensitive to varying loading
onditions (36). Increased LAV seems to be a reliably
easurable indicator of the burden of cardiovascular disease
10), and the remodeled cardiovascular system can be
xpected to be more susceptible to increased adrenergic
tress and dynamic volume changes associated with surgery.
In accordance with these pathophysiological mechanisms,
n a retrospective analysis of patients undergoing mitral
alve surgery, Kernis et al. (5) found anteroposterior LA
imension to be related to POAF, which in turn was
ssociated with a higher incidence of late stroke or conges-
ive heart failure. The LA diameter, however, is known to
ystematically underestimate LAV (14–16). Consequently,
e prospectively assessed LAV from digitally recorded
chocardiographic images in a broader surgical population
nd monitored the postoperative course using continuous
lectronic telemetry recordings. The LAV clearly emerged
o be the strongest predictor of POAF, and we were able to
dentify a clinically useful cutoff that is consistent with
revious population-based literature on LAV and risk pre-
iction (18,37). The only other risk factor of similarigure 3. Survival free from postoperative atrial fibrillation stratified by left
trial volume and age.
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August 15, 2006:779–86 Left Atrial Volume and Postoperative AFtrength was age, which is in accordance with virtually all
tudies on POAF (2,5,6,23). Risk prediction based on two
trictly preoperative parameters, age and LAV, resulted in
n area under the receiver-operator characteristics curve of
.77. A comparable level of discriminative power had so far
nly been obtained in a multicenter study by Mathew et al.
2) using a complex scoring system of mostly postoperative
ariables. The results in the current study were identical
hen considering only the clinically more relevant persistent
OAF (24 h) or when stratifying the patients by preop-
rative beta-blocker use. The proportion of patients with
ersistent POAF increased across LAV quartiles (Fig. 1),
onsistent with a dose-response association suggesting
ausality.
linical implications. Despite a higher rate of beta-
locker administration before and after CABG surgery in
ur study population (88%) compared with a nationwide
ulticentric study (60%) (38), overall, beta-blockers were
sed in less than two-thirds of patients across all types of
ardiac surgery, which included aortic valve replacement. A
arge clinical trial (39) (PAPABEAR [Prophylactic Oral
miodarone for the Prevention of Arrhythmias That Begin
arly After Revascularization, Valve Replacement, or Re-
air]) found amiodarone to be effective in reducing the
ncidence of POAF. However, there were no differences in
erious postoperative complications, in-hospital mortality,
eadmission to the hospital within 6 months of discharge, or
-year mortality. In our observational study, preoperative
herapy with amiodarone to prevent POAF was infrequently
sed and was almost exclusively limited to patients with a
istory of AF, attenuating the increased risk of POAF in
his group. The need for several days of preoperative
reatment, drug-related adverse events observed with
miodarone (39), and costs of the drug most likely contrib-
te to this clinical practice. It is evident that: 1) not all
atients may require preventive treatment, and 2) current
reatment is not adequately targeting the patients at risk for
OAF.
As part of the standard evaluation before cardiac surgery,
chocardiography is useful for preoperative risk stratifica-
ion. The cutoff value of LAV 32 ml/m2 defining an
bnormally large left atrium is consistent with the literature
18,37) and provides clinicians with a practical, noninvasive
ool for identifying those patients who benefit most from
reventive treatment.
tudy strengths and limitations. The strengths of this
tudy include the prospective design, which allowed for
ccurate assessment of the patient’s baseline clinical status
nd outcome. Uninterrupted telemetry recordings until
ospital discharge ensured that no asymptomatic episodes of
OAF were missed and enabled a quantification of POAF.
he proposed risk stratification scheme is simple and relies
n strictly preoperative parameters (LAV and age), making
t useful in clinical practice.
We included most types of cardiac surgery and patients
ith a history of paroxysmal AF to increase the generaliz-bility of our results. When excluding patients with a history
f AF in a separate analysis, the results were unchanged. We
id not include patients with mitral valve surgery or con-
enital heart disease, and therefore our findings cannot be
irectly extrapolated to these groups. In the current study,
he number of postoperative complications other than AF
as too low to detect a risk association, as reported
lsewhere (1–3). The absence of an association between
reoperative medications and POAF in the total population
r in subgroups such as different types of surgery is related
o the nonrandomized nature of our study. Patients on
eta-blockers tended to be at higher risk compared with
atients not on beta-blockers (history of myocardial infarc-
ion p 0.025, previous percutaneous coronary intervention
 0.002, history of hypertension p  0.0003, history of
enal failure p  0.04, greater number of coronary arteries
iseased p  0.03). Our observations are limited to the
eriod of hospitalization; we cannot draw conclusions re-
arding long-term outcomes. Further studies investigating
he predictive value of LAV for long-term outcome and
linical trials to assess the efficacy of targeted preventive
herapy are needed.
onclusions. Postoperative atrial fibrillation is a frequent
omplication after cardiac surgery and is associated with a
rolonged hospital stay. The LAV, as a marker of chroni-
ally increased filling pressures, is strongly related to the
ccurrence of POAF, even after adjusting for other risk
actors. Both LAV and age are useful for preoperative risk
tratification in clinical practice.
eprint requests and correspondence: Dr. Martin Osranek, Divi-
ion of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW,
ochester, Minnesota 55905. E-mail: osranek.martin@mayo.edu.
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